Clin Res Cardiol. 2022 Feb 27.
Interessenskonflikte: Profs. Mahfoud and Böhm are supported by
Deutsche Forschungsgemeinschaft (SFB TRR219). Prof. Mahfoud is
supported by Deutsche Gesellschaft für Kardiologie and has received
scientific support and speaker honoraria from AstraZeneca, Bayer,
Boehringer Ingelheim, Medtronic, and ReCor Medical. Prof. Böhm
has received consulting fees from Abbott Vascular, Bayer AG, Amgen,
AstraZeneca, Servier, Medtronic, Vifor, and Boehringer Ingelheim.
Prof. Kintscher received research grants from Bayer AG, and speaker
honoraria from Amarin, Bayer AG, Berlin Chemie, Novartis, Servier,
and Sanofi, and participated in advisory boards of Berlin Chemie,
Boehringer Ingelheim, Novartis, and Sanofi. All the other authors have
reported that they have no relationships relevant to the contents of this
paper to disclose.